(Q43181687)

15 November 2017

title

Lung cancer and hormone replacement therapy (English)

1 reference

15 November 2017

Marianne Canonico

1

1 reference

15 November 2017

Geneviève Plu-Bureau

series ordinal

2

1 reference

15 November 2017

Pierre-Yves Scarabin

series ordinal

3

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

375

1 reference

15 November 2017

issue

9709

1 reference

15 November 2017

page(s)

117; author reply 118-9

1 reference

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960039-6

7 January 2021

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960039-6

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960039-6

7 January 2021

Another nail in the coffin for hormone-replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960039-6

7 January 2021

10.1016/S0140-6736(10)60039-6

Identifiers

DOI

1 reference

15 November 2017

1 reference